Syncromune
Last verified 2026-05-13. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $144.8Mattributed |
|---|---|
| Latest round | Funding round, $144.8M, 2026-05-11attributed |
| Founded | unknown |
| Headquarters | Fort Lauderdale, FL |
| Industry | biotechnology |
| Stage | unknown |
| Website | syncromune.com |
Clinical-stage biopharmaceutical company developing SYNC-T, an in-situ immunotherapy platform for metastatic solid tumors.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-05-11 | Funding round | $144.8M | undisclosed |
Detected tech stack
Cloudflare, WordPress 7.0, Yoast SEO 27.6, Yoast SEO Premium 27.5, Underscore.js 1.13.8, Kinsta, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, DoubleClick Floodlight, Cloudflare Bot Management, PHP
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $144.8M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $144.8M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | syncromune.com, read 2026-05-13 |
| Description | self-reported | syncromune.com, read 2026-05-13 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $144.8M, 2026-05-11 → Funding round, $144.8M, 2026-05-11, sec-edgar, No document URL on file | Latest round | seed, $144.8M, 2026-05-11 → Funding round, $144.8M, 2026-05-11 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes